EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SIAH2–WNK1 Signaling Drives Glycolytic Metabolism and Therapeutic Resistance in Colorectal Cancer

Kee-Thai Kiu iD, Cheng-Ying Chu iD, Yi-Chiao Cheng iD, Min-Hsuan Yen, Ying-Wei Chen, Narpati Wesa Pikatan iD, Vijesh Kumar Yadav iD, Tung-Cheng Chang iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27021065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Kee-Thai Kiu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Shuang-Ho Hospital, New Taipei City 235, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Glycolysis, Signal Transduction, Drug Resistance, Neoplasm. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Taiwan University of Science and Technology, National Science and Technology Council, Taipei Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) progression and therapy resistance are driven in part by metabolic reprogramming and the persistence of cancer stem-like cells (CSCs). The seven in absentia homolog 2 (SIAH2)/with-no-lysine kinase 1 (WNK1) signaling axis has emerged as a potential regulator of these processes, yet its functional role in CRC metabolism and tumor–stroma crosstalk remains incompletely understood. Integrated analyses of The Cancer Genome Atlas–Colon Adenocarcinoma (TCGA-COAD) and Gene Expression Omnibus (GEO, GSE17538) datasets revealed significant upregulation of SIAH2 and WNK1 in CRC tissues, with strong positive correlations to glycolysis- and hypoxia-associated genes, including PFKP, LDHA, BPGM, ADH1A, ADH1B, and HIF-1α. Single-cell and clinical profiling further demonstrated preferential enrichment of SIAH2 in undifferentiated, stem-like tumor cell populations. Functional studies across multiple CRC cell lines showed that SIAH2 silencing suppressed proliferation, clonogenic growth, tumor sphere formation, and cell-cycle progression, whereas SIAH2 overexpression exerted opposite effects. Seahorse extracellular flux analyses established that SIAH2 promotes glycolytic capacity and metabolic flexibility. At the protein level, SIAH2 regulated glycolytic enzymes and WNK1/hypoxia-inducible factor-1α (HIF-1α) signaling, effects that were amplified by cancer-associated fibroblast (CAF)-derived conditioned medium. CAF exposure enhanced SIAH2 expression, CSC spheroid growth, and resistance to fluorouracil, leucovorin, and oxaliplatin (FOLFOX) chemotherapy, whereas SIAH2 depletion effectively abrogated these effects. Collectively, these findings identify the SIAH2/WNK1 axis as a central metabolic regulator linking glycolysis, CSC maintenance, and microenvironment-driven therapy resistance in CRC, highlighting its potential as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGlycolysisSignal TransductionDrug Resistance, NeoplasmWNK Lysine-Deficient Protein Kinase 1Ubiquitin-Protein LigasesNuclear ProteinsHumansSeven in Absentia ProteinsGene Expression Regulation, NeoplasticCell Line, TumorNeoplastic Stem CellsMetabolic ReprogrammingCell Proliferation

Stichwörter der Autor:innen

SIAH2/WNK1 signalingmetastatic colorectal cancer stem cellstumor fibroblasts

Substanzen

Seven in Absentia ProteinsWNK Lysine-Deficient Protein Kinase 1Ubiquitin-Protein LigasesNuclear ProteinsWNK1 protein, human

Autor:innen und Institutionen

  • Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Shuang-Ho Hospital, New Taipei City 235, Taiwan.
  • Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
  • CRISPR Gene Targeting Core, Taipei Medical University, Taipei 110, Taiwan.
  • TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 110, Taiwan.
  • Division of Colon and Rectal Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei 114, Taiwan.
  • Division of Urology, Department of Surgery, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.

ORCID-Profile: Kee-Thai Kiu, Cheng-Ying Chu, Yi-Chiao Cheng, Narpati Wesa Pikatan, Vijesh Kumar Yadav, Tung-Cheng Chang

Förderung

  • National Taiwan University of Science and Technology
  • National Science and Technology Council
  • Taipei Medical University

Zitieren

APA

Kiu, K. T., Chu, C. Y., Cheng, Y. C., Yen, M. H., Chen, Y. W., Pikatan, N. W., Yadav, V. K., & Chang, T. C. (2026). SIAH2–WNK1 Signaling Drives Glycolytic Metabolism and Therapeutic Resistance in Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27021065

Vancouver

Kiu KT, Chu CY, Cheng YC, Yen MH, Chen YW, Pikatan NW, et al. SIAH2–WNK1 Signaling Drives Glycolytic Metabolism and Therapeutic Resistance in Colorectal Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27021065

BibTeX
@article{Kiu2026,
  author = {Kiu, Kee-Thai and Chu, Cheng-Ying and Cheng, Yi-Chiao and Yen, Min-Hsuan and Chen, Ying-Wei and Pikatan, Narpati Wesa and Yadav, Vijesh Kumar and Chang, Tung-Cheng},
  title = {SIAH2–WNK1 Signaling Drives Glycolytic Metabolism and Therapeutic Resistance in Colorectal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27021065}
}
Kostenlos starten →